异基因造血干细胞移植后口腔和胃肠道继发性癌症发病率增加。 - Suppr | 超能文献

相似文献

1

Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后口腔和胃肠道继发性癌症发病率增加。

Bone Marrow Transplant. 2017 May;52(5):789-791. doi: 10.1038/bmt.2017.4. Epub 2017 Feb 13.

2

Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients.异基因造血干细胞移植受者口腔鳞状细胞癌的相关性

Bone Marrow Transplant. 2007 Nov;40(9):907-9. doi: 10.1038/sj.bmt.1705833. Epub 2007 Aug 27.

3

Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.异基因造血细胞移植后髓系恶性肿瘤复发的第二次异基因造血细胞移植结果：代表西班牙造血移植小组的一项回顾性队列研究

Biol Blood Marrow Transplant. 2016 Mar;22(3):584-8. doi: 10.1016/j.bbmt.2015.11.012. Epub 2015 Nov 26.

4

Solid cancers after bone marrow transplantation.骨髓移植后的实体癌。

J Clin Oncol. 2001 Jan 15;19(2):464-71. doi: 10.1200/JCO.2001.19.2.464.

5

Acute pericarditis before engraftment in hematopoietic stem cell transplantation.造血干细胞移植植入前的急性心包炎。

Bone Marrow Transplant. 2016 Mar;51(3):459-61. doi: 10.1038/bmt.2015.282. Epub 2015 Nov 23.

6

Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study.接受异基因造血干细胞移植的成年澳大利亚人的二次癌症风险和晚期死亡率：一项基于人群的队列研究

Biol Blood Marrow Transplant. 2016 May;22(5):949-56. doi: 10.1016/j.bbmt.2016.01.027. Epub 2016 Feb 6.

7

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC).法国干细胞移植协会（SFGM-TC）的一项回顾性研究：使用无关供者对60岁及以上患有血液系统恶性肿瘤的老年患者进行减低剂量预处理方案后的异基因造血干细胞移植。

Haematologica. 2016 Jun;101(6):e262-5. doi: 10.3324/haematol.2015.139345. Epub 2016 Mar 18.

8

Secondary haploidentical hematopoietic stem cell transplantation in patients with relapse or graft failure after initial hematopoietic stem cell transplantation.初次造血干细胞移植后复发或移植物失败患者的二次单倍型相合造血干细胞移植。

Ann Hematol. 2019 Dec;98(12):2833-2836. doi: 10.1007/s00277-019-03840-6. Epub 2019 Nov 18.

9

Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.接受和未接受造血干细胞移植治疗的儿科癌症患者后续发生的恶性肿瘤。

Bone Marrow Transplant. 2015 May;50(5):721-6. doi: 10.1038/bmt.2015.4. Epub 2015 Feb 23.

10

Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?儿童恶性肿瘤异基因干细胞移植后白细胞亚群中的外周血晚期混合嵌合现象：这重要吗？

Br J Haematol. 2016 Jun;173(6):905-17. doi: 10.1111/bjh.14008. Epub 2016 Mar 21.

引用本文的文献

1

International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.国际移植和细胞治疗长期幸存者的筛查和预防建议：2023 年更新版。

Bone Marrow Transplant. 2024 Jun;59(6):717-741. doi: 10.1038/s41409-023-02190-2. Epub 2024 Feb 27.

2

International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.国际移植和细胞治疗长期幸存者筛查和预防建议：2023 年更新版。

Transplant Cell Ther. 2024 Apr;30(4):349-385. doi: 10.1016/j.jtct.2023.12.001. Epub 2024 Feb 27.

3